Clinical Social Workers in Schertz, TX Accepting Medicare
7 Clinical Social Workers found. Showing 1 - 7
 Denise Joy Thompson, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4324 Golden Oak, Schertz, TX 78154 Phone: 478-319-3444 Fax: 210-957-4099 |
Mrs. Carissma Tempest Hughes Valentine, LCSW-S, DSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1029 Gate Creek Ln, Schertz, TX 78154 Phone: 210-505-9140 |
 Mr. Gilbert Lopez Jr., LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 104 Newrock Crk, Schertz, TX 78154 Phone: 210-501-8851 |
Mr. Richard Anthony Lyons Jr., LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1320 Black Oak Dr, Schertz, TX 78154 Phone: 210-865-0165 |
Kimberlee Morrison, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2513 War Admiral, Schertz, TX 78108 Phone: 210-415-4249 |
Dr. Patricia Ann Shaw, LCSW, PSYD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4925 Battle Lake St, Schertz, TX 78108 Phone: 210-488-1997 |
Mr. Richard Lopez, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2553 Grenada Gait, Schertz, TX 78108 Phone: 210-219-5485 |
News Archive
Framingham cardiovascular risk prediction model from the 1990s still gives the best results
The so-called Framingham cardiovascular risk calculator was developed in 1991 on the basis of data gathered in the USA between 1968 and 1975. It is named after the town of the same name in Massachusetts, where a systematic evaluation of heart health had previously been conducted in the late 1940s.
Enrollment complete in BioSante's LibiGel Phase III cardiovascular and breast cancer safety study
BioSante Pharmaceuticals, Inc., today announced completion of enrollment in its ongoing LibiGel (testosterone gel) Phase III cardiovascular and breast cancer safety study. LibiGel is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.
Surgery may offer best chance of long-term prostate cancer survival
A study from Switzerland suggests that men who have surgery for prostate cancer appear less likely to die of the disease within 10 years than men who choose other treatment options, especially if they are younger or have cancers with certain tumor cell characteristics, according to a report in the Oct. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
PSI second-quarter 2010 revenue increases 10.4% to $502.7 million
Psychiatric Solutions, Inc. today announced financial results for the second quarter ended June 30, 2010. Revenue increased 10.4% for the quarter to $502.7 million from $455.3 million for the second quarter of 2009. Income from continuing operations attributable to PSI stockholders increased 12.9% to $39.0 million for the second quarter of 2010 from $34.6 million for the second quarter last year, and 11.3% per diluted share to $0.69 from $0.62.
University of Washington develops new device to move kidney stones inside body
Almost one in 10 people will someday experience a kidney stone, which creates what is described as the most intense pain imaginable. This increasingly common condition leads to hundreds of thousands of surgeries in the United States each year.
› Verified 6 days ago
Pharmacists
Counselors
Dentists
Occupational Therapists
Clinical Social Workers
Psychologists